
Located in South Asia, Nepal became a signatory of the APLMA roadmap in 2015.
Nepal is part of the WHO E2025 initiative and reported 37 indigenous malaria cases and 2 indigenous deaths in 2024. Its current priorities involve improving surveillance along Points of Entry (POE) along shared land borders with India; ensuring adequate vector control using LLINs in at-risk populations; elimination of presumed/clinical diagnosis and treatment of malaria cases; developing cross-border collaboration to monitor and manage the importation of malaria cases, primarily from malaria-endemic bordering districts of India; and preparing for WHO malaria elimination certification.
Nepal is an E2025 country that has developed proven models for the management of cross-border malaria in the region.
Currently among the countries making up 1% of the Asia Pacific’s malaria burden, Nepal aims to eliminate malaria by 2027.